Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
S. L. Neha, Ashwini Kumar Mishra, Laxmi Rani, Shweta Paroha, Hitesh Kumar Dewangan & Pravat Kumar Sahoo. (2023) Design and evaluations of a nanostructured lipid carrier loaded with dopamine hydrochloride for intranasal bypass drug delivery in Parkinson’s disease. Journal of Microencapsulation 40:8, pages 599-612.
Read now
Read now
Tulshidas S. Patil & Ashwini S. Deshpande. (2021) Design, development, and characterisation of clofazimine-loaded mannosylated nanostructured lipid carriers: 33-Box-Behnken design approach. Materials Technology 36:8, pages 460-475.
Read now
Read now
Osama A A Ahmed, Usama A Fahmy, Rana Bakhaidar, Mohamed A El-Moselhy, Mohamed A Alfaleh, Al-Shaimaa F Ahmed, Asmaa S A Hammad, Hibah Aldawsari & Nabil A Alhakamy. (2020) Pumpkin Oil–Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats. International Journal of Nanomedicine 15, pages 2529-2539.
Read now
Read now
Amr Ehab Kamel, Maha Fadel & Dina Louis. (2019) Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line. International Journal of Nanomedicine 14, pages 5073-5085.
Read now
Read now
Tulshidas S. Patil, Ashwini S. Deshpande, Shirish Deshpande & Pravin Shende. (2019) Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need. Journal of Drug Targeting 27:1, pages 12-27.
Read now
Read now
Nimitt V. Chokshi, Hiren N. Khatri & Mayur M. Patel. (2018) Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis. Drug Development and Industrial Pharmacy 44:12, pages 1975-1989.
Read now
Read now
Alexandre C. C. Vieira, Luíse L. Chaves, Marina Pinheiro, Sofia A. Costa Lima, Domingos Ferreira, Bruno Sarmento & Salette Reis. (2018) Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 653-663.
Read now
Read now
Articles from other publishers (68)
Zeqing Bao, Fion Yung, Riley J. Hickman, Alán Aspuru-Guzik, Pauric Bannigan & Christine Allen. (2023) Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug. Drug Delivery and Translational Research.
Crossref
Crossref
Simpal Kumar Suman, Natarajan Chandrasekaran & C. George Priya Doss. (2023) Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments. Clinical Microbiology Reviews 36:4.
Crossref
Crossref
Hitesh Kumar, Pallavi Chand, Shantanu Pachal, Sahid Mallick, Rupshee Jain, SubbaRao V. Madhunapantula & Vikas Jain. (2023) Fisetin-Loaded Nanostructured Lipid Carriers: Formulation and Evaluations against Advanced and Metastatic Melanoma. Molecular Pharmaceutics 20:12, pages 6035-6055.
Crossref
Crossref
Samarjit Ghosh, Triveni Tiwari, Upendra Nagaich & Neha Jain. (2023) A Detailed Insight into Nanostructured Lipid Carriers: A Versatile Drug
Delivery System. Recent Patents on Nanotechnology 17:4, pages 284-306.
Crossref
Crossref
Alok Kumar Mahor, Prem Prakash Singh, Rishikesh Gupta, Peeyush Bhardwaj, Priyanka Rathore, Ankita Kishore, Rohit Goyal, Neeraj Sharma, Jyoti Verma, Jessica M. Rosenholm & Kuldeep K. Bansal. (2023) Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route. Journal of Nanotechnology 2023, pages 1-35.
Crossref
Crossref
Maria Inês Teixeira, Carla M. Lopes, Hugo Gonçalves, José Catita, Ana Margarida Silva, Francisca Rodrigues, Maria Helena Amaral & Paulo C. Costa. (2023) Riluzole-loaded lipid nanoparticles for brain delivery: Preparation, optimization and characterization. Journal of Molecular Liquids 388, pages 122749.
Crossref
Crossref
Mahesh Kumar, Tarun Virmani, Girish Kumar, Rohitas Deshmukh, Ashwani Sharma, Sofia Duarte, Pedro Brandão & Pedro Fonte. (2023) Nanocarriers in Tuberculosis Treatment: Challenges and Delivery Strategies. Pharmaceuticals 16:10, pages 1360.
Crossref
Crossref
Amol S. Shinde & Rita R. Lala. (2023) Mannose-anchored solid lipid nanoparticles loaded with atorvastatin calcium and vinpocetine as targeted therapy for breast cancer. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Crossref
Alakbar Huseynzada, Mirjavid Aghayev, Sarvinaz Hajiyeva, Aygun Israyilova, Koray Sayin, Eldar Gasimov, Fuad Rzayev, Ulviyya Hasanova, Goncha Eyvazova, Vagif Abbasov, Zarema Gakhramanova, Sanam Huseynova, Parvana Huseynova, Lala Huseynova & Nigar Salimova. (2023)
Synthesis, nanostructuring and
in silico
studies of a new imine bond containing a macroheterocycle as a promising PBP-2a non-β-lactam inhibitor
. Journal of Materials Chemistry B 11:34, pages 8271-8280.
Crossref
Crossref
Shaveta Ahalwat, Dinesh Chandra Bhatt, Surbhi Rohilla, Vikas Jogpal, Kirti Sharma, Tarun Virmani, Girish Kumar, Abdulsalam Alhalmi, Ali S. Alqahtani, Omar M. Noman & Marwan Almoiliqy. (2023) Mannose-Functionalized Isoniazid-Loaded Nanostructured Lipid Carriers for Pulmonary Delivery: In Vitro Prospects and In Vivo Therapeutic Efficacy Assessment. Pharmaceuticals 16:8, pages 1108.
Crossref
Crossref
Hitesh Kumar, N. Vishal Gupta, Rupshee Jain, SubbaRao V. Madhunapantula, Saravana Babu, Surajit Dey, Anshita Gupta Soni & Vikas Jain. (2023) F3 peptide functionalized liquid crystalline nanoparticles for delivering Salinomycin against breast cancer. International Journal of Pharmaceutics 643, pages 123226.
Crossref
Crossref
Dibyalochan Mohanty, Omar Awad Alsaidan, Ameeduzzafar Zafar, Trishala Dodle, Jeetendra Kumar Gupta, Mohd Yasir, Anshuman Mohanty & Mohammad Khalid. (2023) Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation. Pharmaceutics 15:7, pages 1985.
Crossref
Crossref
Xiomara Calderón‐Colón, Yichuan Zhang, Olivia Tiburzi, Jialu Wang, Shenda Hou, Giorgio Raimondi & Julia Patrone. (2022) Design and characterization of lipid nanocarriers for oral delivery of immunotherapeutic peptides. Journal of Biomedical Materials Research Part A 111:7, pages 938-949.
Crossref
Crossref
Popat S. Kumbhar, Arehalli S. Manjappa, Rohit R. Shah, Sameer J. Nadaf & John I. Disouza. (2023) Nanostructured Lipid Carrier–Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization. AAPS PharmSciTech 24:5.
Crossref
Crossref
Jakarwan Yostawonkul, Sirikorn Kitiyodom, Kittipat Supchukun, Nutthanit Thumrongsiri, Nattika Saengkrit, Komkiew Pinpimai, Amin Hajitou, Kim D. Thompson, Kasem Rattanapinyopituk, Masashi Maita, Manoj Tukaram Kamble, Teerapong Yata & Nopadon Pirarat. (2023) Masculinization of Red Tilapia (Oreochromis spp.) Using 17α-Methyltestosterone-Loaded Alkyl Polyglucosides Integrated into Nanostructured Lipid Carriers. Animals 13:8, pages 1364.
Crossref
Crossref
Nagarajan Usharani, Swarna Vinodh Kanth & Natarajan Saravanan. (2023) Current nanotechnological strategies using lipids, carbohydrates, proteins and metal conjugates-based carrier systems for diagnosis and treatment of tuberculosis — A review. International Journal of Biological Macromolecules 227, pages 262-272.
Crossref
Crossref
Vasanti Suvarna, Niserga Sawant & Namita Desai. (2023) A Review on Recent Advances in Mannose-Functionalized Targeted Nanocarrier Delivery Systems in Cancer and Infective Therapeutics. Critical Reviews™ in Therapeutic Drug Carrier Systems 40:2, pages 43-82.
Crossref
Crossref
Dhwani Rana, Sagar Salave, Ritu Patel, Dignesh Khunt, Manju Misra, Bhupendra Prajapati, Geeta Patel & Jayvadan Patel. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems
99
121
.
Jivesh Garg, Khushboo Pathania, Sangeeta Pilkhwal Sah & Sandip V. Pawar. (2022) Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Crossref
Sana Kalave, Namita Hegde & Kapil Juvale. (2022) Applications of Nanotechnology-based Approaches to Overcome Multi-drug
Resistance in Cancer. Current Pharmaceutical Design 28:38, pages 3140-3157.
Crossref
Crossref
Tochukwu Chimdindu Okeke, Chukwuebuka Emmanuel Umeyor, Ifeanyi Thaddeus Nzekwe, Immaculeta Chikamnele Umeyor, Ngozi Maryann Nebolisa, Emmanuel Maduabuchi Uronnachi, Calistus Dozie Nwakile, Chizoba Austinline Ekweogu, Omoirri Moses Aziakpono & Anthony Amaechi Attama. (2022)
Formulation Development of
Azadirachta indica
Extract as Nanosuppository
to Improve its Intrarectal Delivery for the Treatment of Malaria
. Recent Advances in Drug Delivery and Formulation 16:3, pages 217-233.
Crossref
Crossref
Nitin Verma, Vimal Arora, Rajendra Awasthi, Yinghan Chan, Niraj Kumar Jha, Komal Thapa, Talha Jawaid, Mehnaz Kamal, Gaurav Gupta, Gang Liu, Keshav Raj Paudel, Philip Michael Hansbro, Brian Gregory George Oliver, Sachin Kumar Singh, Dinesh Kumar Chellappan, Harish Dureja & Kamal Dua. (2022) Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis. Journal of Drug Delivery Science and Technology 75, pages 103690.
Crossref
Crossref
Heba S. Elsewedy, Tamer M. Shehata & Wafaa E. Soliman. (2022) Tea Tree Oil Nanoemulsion-Based Hydrogel Vehicle for Enhancing Topical Delivery of Neomycin. Life 12:7, pages 1011.
Crossref
Crossref
Mani Sharma & Sakshi Kansal. 2022. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity
317
347
.
Heba S. Elsewedy, Tamer M. Shehata, Mervt M. Almostafa & Wafaa E. Soliman. (2022) Hypolipidemic Activity of Olive Oil-Based Nanostructured Lipid Carrier Containing Atorvastatin. Nanomaterials 12:13, pages 2160.
Crossref
Crossref
Anirudh Gairola, Aaron Benjamin, Joshua D. Weatherston, Jeffrey D. Cirillo & Hung‐Jen Wu. (2022) Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages. Advanced Therapeutics 5:6.
Crossref
Crossref
Neda Karimi-Khorrami, Mohsen Radi, Sedigheh Amiri, Elahe Abedi & David Julian McClements. (2022) Fabrication, characterization, and performance of antimicrobial alginate-based films containing thymol-loaded lipid nanoparticles: Comparison of nanoemulsions and nanostructured lipid carriers. International Journal of Biological Macromolecules 207, pages 801-812.
Crossref
Crossref
Shamama Javed, Bharti Mangla, Yosif Almoshari, Muhammad H. Sultan & Waquar Ahsan. (2022) Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews 11:1, pages 1744-1777.
Crossref
Crossref
Pratik Kakade, Arkasubhro Chatterjee, Anjali Pandya, John Disouza & Vandana Patravale. (2022) Carbohydrate anchored lipid nanoparticles. International Journal of Pharmaceutics 618, pages 121681.
Crossref
Crossref
Joandra Maísa da Silva Leite, Yuri Basilio Gomes Patriota, Mônica Felts de La Roca & José Lamartine Soares-Sobrinho. (2022) New Perspectives in Drug Delivery Systems for the Treatment of
Tuberculosis. Current Medicinal Chemistry 29:11, pages 1936-1958.
Crossref
Crossref
Kabi Raj Chaudhary, Vishal Puri, Arti Singh & Charan Singh. (2022) A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis. Journal of Drug Delivery Science and Technology 69, pages 103069.
Crossref
Crossref
Maharshi Thalla & Subham Banerjee. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
371
410
.
Filipa Santos & Ana Rita C. Duarte. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases
173
210
.
Santwana Padhi & Anindita Behera. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
523
537
.
Amarjitsing Rajput, Satish Mandlik & Varsha Pokharkar. (2021) Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis. Frontiers in Pharmacology 12.
Crossref
Crossref
Aristote B. Buya, Bwalya A. Witika, Alain M. Bapolisi, Chiluba Mwila, Grady K. Mukubwa, Patrick B. Memvanga, Pedzisai A. Makoni & Christian I. Nkanga. (2021) Application of Lipid-Based Nanocarriers for Antitubercular Drug Delivery: A Review. Pharmaceutics 13:12, pages 2041.
Crossref
Crossref
C.P. Costa, S. Cunha, J.N. Moreira, R. Silva, E. Gil-Martins, V. Silva, L. Azevedo, A.F. Peixoto, J.M. Sousa Lobo & A.C. Silva. (2021) Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells. International Journal of Pharmaceutics 607, pages 120933.
Crossref
Crossref
Ali Sabouri Shirazi, Reyhaneh Varshochian, Mahsa Rezaei, Yalda Hosseinzadeh Ardakani & Rassoul Dinarvand. (2021) SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma. Journal of Materials Science: Materials in Medicine 32:7.
Crossref
Crossref
Adejumoke Lara Ajiboye, Uttom Nandi, Martin Galli & Vivek Trivedi. (2021) Olanzapine Loaded Nanostructured Lipid Carriers via High Shear Homogenization and Ultrasonication. Scientia Pharmaceutica 89:2, pages 25.
Crossref
Crossref
Nimitt V. Chokshi, Shruti Rawal, Dhruvi Solanki, Saumitra Gajjar, Vivek Bora, Bhoomika M. Patel & Mayur M. Patel. (2021) Fabrication and Characterization of Surface Engineered Rifampicin Loaded Lipid Nanoparticulate Systems for the Potential Treatment of Tuberculosis: An In Vitro and In Vivo Evaluation. Journal of Pharmaceutical Sciences 110:5, pages 2221-2232.
Crossref
Crossref
Aldemar Gordillo-Galeano, Luis Fernando Ospina-Giraldo & Claudia Elizabeth Mora-Huertas. (2021) Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment. International Journal of Pharmaceutics 596, pages 120321.
Crossref
Crossref
Pallavi Chand, Hitesh Kumar, Nihal Badduri, N. Vishal Gupta, Vidya G. Bettada, SubbaRao V. Madhunapantula, Siddharth S. Kesharwani, Surajit Dey & Vikas Jain. (2021) Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines. Colloids and Surfaces B: Biointerfaces 199, pages 111535.
Crossref
Crossref
Priya Shrivastava, Laxmikant Gautam, Anamika Jain, Nikhar Vishwakarma, Sonal Vyas & Suresh P. Vyas. 2021. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer. Handbook of Research on Nano-Strategies for Combatting Antimicrobial Resistance and Cancer
87
113
.
Alexandre C.C. Vieira, Luíse L. Chaves, Marina Pinheiro, Sofia Costa Lima, Pedro José Rolim Neto, Domingos Ferreira, Bruno Sarmento & Salette Reis. (2021) Lipid nanoparticles coated with chitosan using a one-step association method to target rifampicin to alveolar macrophages. Carbohydrate Polymers 252, pages 116978.
Crossref
Crossref
Himanshu Gandhi, Shikha Mahant, Amit Bansal & Deepak N. Kapoor. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
717
740
.
Zsuzsa Baranyai, Héctor Soria‐Carrera, Maria Alleva, Ana C. Millán‐Placer, Ainhoa Lucía, Rafael Martín‐Rapún, José A. Aínsa & Jesús M. de la Fuente. (2020) Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis. Advanced Therapeutics 4:1.
Crossref
Crossref
Khaled H. AlzahabiOmar UsmaniTheoni K. GeorgiouMary P. RyanBrian D. RobertsonTeresa D. TetleyAlexandra E. Porter. (2020) Approaches to treating tuberculosis by encapsulating metal ions and anti-mycobacterial drugs utilizing nano- and microparticle technologies. Emerging Topics in Life Sciences 4:6, pages 581-600.
Crossref
Crossref
Meenu Mehta, Daljeet Singh Dhanjal, Saurabh Satija, Ridhima Wadhwa, Keshav Raj Paudel, Dinesh Kumar Chellappan, Shiva Mohammad, Mehra Haghi, Philip M. Hansbro & Kamal Dua. (2020) Advancing of Cellular Signaling Pathways in Respiratory Diseases Using Nanocarrier Based Drug Delivery Systems. Current Pharmaceutical Design 26:42, pages 5380-5392.
Crossref
Crossref
Yong-Chul Pyo, Phuong Tran, Dong-Hyun Kim & Jeong-Sook Park. (2020) Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy. Colloids and Surfaces B: Biointerfaces 196, pages 111331.
Crossref
Crossref
Gabriela HädrichRaphael Aparecido BoscheroArthur Sperry AppelMariana FalkembachMatheus MonteiroPedro Eduardo Almeida da SilvaLea Ann DaileyCristiana Lima Dora. (2020) Tuberculosis Treatment Facilitated by Lipid Nanocarriers: Can Inhalation Improve the Regimen?. ASSAY and Drug Development Technologies 18:7, pages 298-307.
Crossref
Crossref
Bushra Nabi, Saleha Rehman, Sumit Aggarwal, Sanjula Baboota & Javed Ali. (2020) Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention. Drug Delivery and Translational Research 10:4, pages 1111-1121.
Crossref
Crossref
Tulshidas S. Patil & Ashwini S. Deshpande. (2020) Mannosylated nanocarriers mediated site-specific drug delivery for the treatment of cancer and other infectious diseases: A state of the art review. Journal of Controlled Release 320, pages 239-252.
Crossref
Crossref
Eleonora Truzzi, Thais Leite Nascimento, Valentina Iannuccelli, Luca Costantino, Eliana Martins Lima, Eliana Leo, Cristina Siligardi, Magdalena Lassinantti Gualtieri & Eleonora Maretti. (2020) In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?. Nanomaterials 10:3, pages 568.
Crossref
Crossref
Iti Chauhan, Mohd YasirMadhu VermaAlok Pratap Singh. (2020) Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery. Advanced Pharmaceutical Bulletin 10:2, pages 150-165.
Crossref
Crossref
Jiang Pi, Ling Shen, Enzhuo Yang, Hongbo Shen, Dan Huang, Richard Wang, Chunmiao Hu, Hua Jin, Huaihong Cai, Jiye Cai, Gucheng Zeng & Zheng W. Chen. (2020) Macrophage‐Targeted Isoniazid–Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli. Angewandte Chemie International Edition 59:8, pages 3226-3234.
Crossref
Crossref
Jiang Pi, Ling Shen, Enzhuo Yang, Hongbo Shen, Dan Huang, Richard Wang, Chunmiao Hu, Hua Jin, Huaihong Cai, Jiye Cai, Gucheng Zeng & Zheng W. Chen. (2020) Macrophage‐Targeted Isoniazid–Selenium Nanoparticles Promote Antimicrobial Immunity and Synergize Bactericidal Destruction of Tuberculosis Bacilli. Angewandte Chemie 132:8, pages 3252-3260.
Crossref
Crossref
Joana Magalhães, Marina Pinheiro, Barbara Drasler, Dedy Septiadi, Alke Petri-Fink, Susana G Santos, Barbara Rothen-Rutishauser & Salette Reis. (2020) Lipid nanoparticles biocompatibility and cellular uptake in a 3D human lung model. Nanomedicine 15:3, pages 259-271.
Crossref
Crossref
Simone Pinto Carneiro & Orlando David Henrique dos Santos. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
193
205
.
Elham Sadati Behbahani, Mehrorang Ghaedi, Mohammadreza Abbaspour, Kobra Rostamizadeh & Kheibar Dashtian. (2019) Curcumin loaded nanostructured lipid carriers: In vitro digestion and release studies. Polyhedron 164, pages 113-122.
Crossref
Crossref
Eleonora Maretti, Luca Costantino, Francesca Buttini, Cecilia Rustichelli, Eliana Leo, Eleonora Truzzi & Valentina Iannuccelli. (2018) Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy. Drug Delivery and Translational Research 9:1, pages 298-310.
Crossref
Crossref
Xin Ying Lee, Chee Chin Chu, Zafarizal Aldrin Bin Azizul Hasan, Siaw Kim Chua & Kar Lin Nyam. (2019) Novel Nanostructured Lipid Carriers with Photoprotective Properties Made from Carnauba Wax, Beeswax, and Kenaf Seed Oil. Journal of the American Oil Chemists' Society 96:2, pages 201-211.
Crossref
Crossref
Hiren Khatri, Nimitt Chokshi, Shruti Rawal & Mayur M Patel. (2019) Fabrication, characterization and optimization of artemether loaded PEGylated solid lipid nanoparticles for the treatment of lung cancer. Materials Research Express 6:4, pages 045014.
Crossref
Crossref
Diana P. Gaspar & António J. Almeida. 2019. Surface Modification of Nanoparticles for Targeted Drug Delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery
73
98
.
Kamal Dua, Vamshi Krishna Rapalli, Shakti Dhar Shukla, Gautam Singhvi, Madhur D. Shastri, Dinesh Kumar Chellappan, Saurabh Satija, Meenu Mehta, Monica Gulati, Terezinha De Jesus Andreoli Pinto, Gaurav Gupta & Philip M. Hansbro. (2018) Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches. Biomedicine & Pharmacotherapy 107, pages 1218-1229.
Crossref
Crossref
Tulshidas S. Patil & Ashwini S. Deshpande. (2018) Nanostructured lipid carriers-based drug delivery for treating various lung diseases: A State‐of‐the‐Art Review. International Journal of Pharmaceutics 547:1-2, pages 209-225.
Crossref
Crossref
Alexandre C.C. Vieira, Luíse L. Chaves, Sara Pinheiro, Soraia Pinto, Marina Pinheiro, Sofia Costa Lima, Domingos Ferreira, Bruno Sarmento & Salette Reis. (2018) Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis. International Journal of Pharmaceutics 536:1, pages 478-485.
Crossref
Crossref
Alexandre CC Vieira, Joana Magalhães, Sónia Rocha, Marcos S Cardoso, Susana G Santos, Margarida Borges, Marina Pinheiro & Salette Reis. (2017) Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment. Nanomedicine 12:24, pages 2721-2736.
Crossref
Crossref
Eleonora Maretti, Luca Costantino, Cecilia Rustichelli, Eliana Leo, Maria Antonietta Croce, Francesca Buttini, Eleonora Truzzi & Valentina Iannuccelli. (2017) Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α- d -mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy. International Journal of Pharmaceutics 528:1-2, pages 440-451.
Crossref
Crossref